AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Johannes, S Wieringa, BM Nager, W Muller-Vahl, KR Dengler, R Munte, TF
Citation: S. Johannes et al., Electrophysiological measures and dual-task performance in Tourette syndrome indicate deficient divided attention mechanisms, EUR J NEUR, 8(3), 2001, pp. 253-260

Authors: Muller-Vahl, KR Koblenz, A Jobges, M Kolbe, H Emrich, HM Schneider, U
Citation: Kr. Muller-vahl et al., Influence of treatment of Tourette syndrome with Delta(9)-tetrahydrocannabinol (Delta(9)-THC) on neuropsychological performance, PHARMACOPS, 34(1), 2001, pp. 19-24

Authors: Johannes, S Wieringa, BM Mantey, M Nager, W Rada, D Muller-Vahl, KR Emrich, HM Dengler, R Munte, TF Dietrich, D
Citation: S. Johannes et al., Altered inhibition of motor responses in Tourette Syndrome and Obsessive-Compulsive Disorder, ACT NEUR SC, 104(1), 2001, pp. 36-43

Authors: Schneider, U Muller-Vahl, KR Stuhrmann, M Gadzicki, D Heller, D Seifert, J Emrich, HM
Citation: U. Schneider et al., The importance of the endogenous cannabinoid system in various neuropsychiatric disorders, F NEUR PSYC, 68(10), 2000, pp. 433-438

Authors: Muller-Vahl, KR Berding, G Brucke, T Kolbe, H Meyer, GJ Hundeshagen, H Dengler, R Knapp, WH Emrich, HM
Citation: Kr. Muller-vahl et al., Dopamine transporter binding in Gilles de la Tourette syndrome, J NEUROL, 247(7), 2000, pp. 514-520

Authors: Muller-Vahl, KR Kolbe, H Egensperger, R Dengler, R
Citation: Kr. Muller-vahl et al., Mitochondriopathy, blepharospasm, and treatment with botulinum toxin, MUSCLE NERV, 23(4), 2000, pp. 647-648

Authors: Muller-Vahl, KR Berding, G Kolbe, H Meyer, GJ Hundeshagen, H Dengler, R Knapp, WH Emrich, HM
Citation: Kr. Muller-vahl et al., Dopamine D-2 receptor imaging in Gilles de la Tourette syndrome, ACT NEUR SC, 101(3), 2000, pp. 165-171

Authors: Muller-Vahl, KR Kolbe, H Schneider, U Emrich, HM
Citation: Kr. Muller-vahl et al., Cannabis in movement disorders, FORSCH KOMP, 6, 1999, pp. 23-27

Authors: Muller-Vahl, KR Schneider, U Emrich, HM
Citation: Kr. Muller-vahl et al., Nabilone increases choreatic movements in Huntington's disease, MOVEMENT D, 14(6), 1999, pp. 1038-1040

Authors: Schneider, U Bevilacqua, C Jacobs, R Karst, M Dietrich, DE Becker, H Muller-Vahl, KR Seeland, I Gielsdorf, D Schedlowski, M Emrich, HM
Citation: U. Schneider et al., Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects, NEUROPSYCHB, 39(1), 1999, pp. 38-43

Authors: Schneider, U Wohlfarth, K Schulze-Bonhage, A Haacker, T Muller-Vahl, KR Zedler, M Becker, H Dengler, R Emrich, HM
Citation: U. Schneider et al., Effects of acamprosate on memory in healthy young subjects, J STUD ALC, 60(2), 1999, pp. 172-175

Authors: Muller-Vahl, KR Kolbe, H Dengler, R
Citation: Kr. Muller-vahl et al., Transient severe parkinsonism after acute organophosphate poisoning, J NE NE PSY, 66(2), 1999, pp. 253-254

Authors: Muller-Vahl, KR Schneider, U Kolbe, H Emrich, HM
Citation: Kr. Muller-vahl et al., Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol, AM J PSYCHI, 156(3), 1999, pp. 495-495

Authors: Muller-Vahl, KR Muller-Vahl, HG
Citation: Kr. Muller-vahl et Hg. Muller-vahl, Idiopathic autonomic neuropathy, an important disease in differential diagnosis, DEUT MED WO, 123(45), 1998, pp. 1343-1346

Authors: Muller-Vahl, KR Kolbe, H Schneider, U Emrich, HM
Citation: Kr. Muller-vahl et al., Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome, ACT PSYC SC, 98(6), 1998, pp. 502-506
Risultati: 1-15 |